The deal would hand Lilly an experimental pill that could one day rival Takeda's blockbuster medicine Entyvio as a treatment for inflammatory bowel disease.
More from Jacob Bell
Lilly to buy Morphic in $3B bet on inflammation drug
No Comments
Leave a comment Cancel